Ottawa and Montreal will be the two Canadian sites for the international vaccine trial that is looking for information about the safety and effectiveness of the vaccine in building a protective immune response among HIV-positive people.  Read more: http://ottawacitizen.com/news/local-news/ottawa-among-the-sites-that-will-test-ebola-vaccine-in-hiv-positive-people